Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 29 studies | 33% ± 14% | |
endothelial cell | 26 studies | 33% ± 16% | |
smooth muscle cell | 21 studies | 32% ± 11% | |
fibroblast | 16 studies | 27% ± 8% | |
astrocyte | 12 studies | 38% ± 14% | |
oligodendrocyte | 11 studies | 32% ± 11% | |
endothelial cell of lymphatic vessel | 10 studies | 27% ± 10% | |
glutamatergic neuron | 10 studies | 52% ± 23% | |
oligodendrocyte precursor cell | 10 studies | 35% ± 14% | |
type I pneumocyte | 9 studies | 35% ± 11% | |
GABAergic neuron | 8 studies | 47% ± 21% | |
epithelial cell | 8 studies | 38% ± 20% | |
basal cell | 8 studies | 28% ± 15% | |
adipocyte | 8 studies | 23% ± 5% | |
microglial cell | 7 studies | 27% ± 10% | |
ciliated cell | 7 studies | 27% ± 9% | |
capillary endothelial cell | 6 studies | 19% ± 4% | |
amacrine cell | 6 studies | 29% ± 6% | |
interneuron | 6 studies | 48% ± 18% | |
neuron | 6 studies | 41% ± 14% | |
type II pneumocyte | 6 studies | 27% ± 6% | |
B cell | 5 studies | 22% ± 2% | |
natural killer cell | 5 studies | 17% ± 1% | |
myofibroblast cell | 5 studies | 27% ± 10% | |
retina horizontal cell | 5 studies | 31% ± 11% | |
cardiac muscle cell | 5 studies | 26% ± 4% | |
club cell | 5 studies | 29% ± 9% | |
T cell | 4 studies | 19% ± 3% | |
squamous epithelial cell | 4 studies | 52% ± 22% | |
CD4-positive, alpha-beta T cell | 4 studies | 19% ± 5% | |
retinal bipolar neuron | 4 studies | 21% ± 3% | |
granule cell | 4 studies | 38% ± 15% | |
macrophage | 4 studies | 31% ± 11% | |
retinal ganglion cell | 4 studies | 34% ± 12% | |
lymphocyte | 4 studies | 26% ± 6% | |
secretory cell | 4 studies | 22% ± 5% | |
endothelial cell of vascular tree | 4 studies | 29% ± 14% | |
muscle cell | 4 studies | 47% ± 17% | |
connective tissue cell | 4 studies | 20% ± 1% | |
GABAergic interneuron | 3 studies | 34% ± 8% | |
glial cell | 3 studies | 27% ± 7% | |
vein endothelial cell | 3 studies | 28% ± 15% | |
rod bipolar cell | 3 studies | 41% ± 8% | |
cholangiocyte | 3 studies | 52% ± 17% | |
hepatocyte | 3 studies | 39% ± 26% | |
pancreatic ductal cell | 3 studies | 32% ± 10% | |
ependymal cell | 3 studies | 30% ± 16% | |
transit amplifying cell | 3 studies | 37% ± 28% | |
brush cell | 3 studies | 28% ± 7% | |
mucus secreting cell | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 16897.45 | 1445 / 1445 | 100% | 32.73 | 183 / 183 |
brain | 100% | 21504.43 | 2641 / 2642 | 100% | 55.97 | 704 / 705 |
skin | 100% | 15084.64 | 1808 / 1809 | 100% | 38.89 | 470 / 472 |
thymus | 100% | 22891.35 | 653 / 653 | 100% | 41.91 | 602 / 605 |
pancreas | 100% | 10173.95 | 327 / 328 | 99% | 36.31 | 177 / 178 |
intestine | 100% | 16058.32 | 966 / 966 | 99% | 22.80 | 522 / 527 |
prostate | 100% | 15943.41 | 245 / 245 | 99% | 21.90 | 496 / 502 |
breast | 100% | 17383.81 | 459 / 459 | 99% | 25.12 | 1104 / 1118 |
stomach | 100% | 15061.61 | 359 / 359 | 99% | 25.94 | 282 / 286 |
bladder | 100% | 18026.48 | 21 / 21 | 98% | 24.52 | 496 / 504 |
uterus | 100% | 28175.39 | 170 / 170 | 98% | 29.58 | 451 / 459 |
lung | 100% | 23779.39 | 578 / 578 | 98% | 25.81 | 1134 / 1155 |
kidney | 100% | 14333.24 | 89 / 89 | 98% | 28.85 | 882 / 901 |
adrenal gland | 100% | 12157.73 | 258 / 258 | 95% | 28.62 | 218 / 230 |
ovary | 100% | 17467.54 | 180 / 180 | 89% | 14.38 | 383 / 430 |
liver | 100% | 8061.04 | 226 / 226 | 76% | 10.53 | 308 / 406 |
adipose | 100% | 19306.38 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 33859.12 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 43.94 | 80 / 80 |
muscle | 100% | 16355.15 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 15651.03 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.08 | 1 / 1 |
heart | 99% | 17491.91 | 856 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 17.02 | 27 / 29 |
peripheral blood | 40% | 3591.31 | 369 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005925 | Cellular component | focal adhesion |
GO_0045296 | Molecular function | cadherin binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MPRIP |
Protein name | Myosin phosphatase Rho interacting protein Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip) MPRIP protein |
Synonyms | MRIP KIAA0864 RHOIP3 |
Description | FUNCTION: Targets myosin phosphatase to the actin cytoskeleton. Required for the regulation of the actin cytoskeleton by RhoA and ROCK1. Depletion leads to an increased number of stress fibers in smooth muscle cells through stabilization of actin fibers by phosphorylated myosin. Overexpression of MRIP as well as its F-actin-binding region leads to disassembly of stress fibers in neuronal cells. . |
Accessions | ENST00000577514.5 ENST00000584067.5 A8MZF8 Q6WCQ1 H0Y2S9 ENST00000466186.2 ENST00000651222.2 J3KSW8 J3QRL2 B9EGI2 A0A1W2PPU9 J3QL44 ENST00000341712.8 [Q6WCQ1-1] ENST00000579832.1 Q96EE5 H0Y7E2 A0A494BZV2 ENST00000313485.10 H7C3G6 ENST00000414263.5 ENST00000395806.5 ENST00000462033.1 ENST00000578209.5 J3KSK7 K7EJ14 ENST00000429184.7 K7EL39 ENST00000579361.1 ENST00000395811.9 [Q6WCQ1-2] |